Alternative Schedule of Velcade/Dexamethasone Plus Doxil for Patients With Multiple Myeloma

Stopped Study was closed to enrollment when it became clear that enrollment was too slow to complete full enrollment target within time frame allowed.

Conditions

• Multiple Myeloma

Interventions

• DRUG: bortezomib
• DRUG: dexamethasone
• DRUG: doxorubicin HCl liposome

Sponsor

Accelerated Community Oncology Research Network

Collaborators

• [object Object]